Cancer cells resistance to antiproliferative signaling occurs through mutations in pro-apoptotic genes like p53 and activation of survival pathways such as PI3K-AKT/PKB (Hanahan, 2022; Hanahan and Weinberg, 2000). Here, TP53 is linked to cancer.